GlassScriptPhysician profile
Matthew G Cable
NPI 1104054832
$78,591.14
in general payments reported to CMS, 2019-2025
34 companies · $5,486 in 2025
The $5,486 reported for 2025 was more than what 83% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $967 · 2020: $2,410 · 2021: $3,568 · 2022: $9,997 · 2023: $10K · 2024: $46K · 2025: $5,486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $39K · Food and Beverage: $8,786 · Travel and Lodging: $8,470 · Honoraria: $5,255 · Consulting Fee: $52.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $39,085.00 |
| Food and Beverage | $8,786.34 |
| Travel and Lodging | $8,470.05 |
| Honoraria | $5,255.00 |
| Consulting Fee | $52.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $53,038.61 | 2022-2025 | Osteocool Rf Ablation System, Intellis Adaptivestim, Accurian |
| Musculoskeletal Transplant Foundation INC. | $5,600.09 | 2021-2024 | |
| Stryker Corporation | $4,642.17 | 2019-2025 | Mako, Triathlon, Blueprint Patient Specific Instrumentation |
| Carbofix Orthopedics INC | $3,697.14 | 2021-2025 | |
| Deciphera Pharmaceuticals INC. | $2,569.27 | 2024 | Vimseltinib |
| Daiichi Sankyo INC. | $2,117.50 | 2020 | |
| Alon Medical Technology | $1,200.00 | 2021 | |
| Merete Technologies, INC | $1,000.00 | 2022 | |
| Onkos Surgical, INC. | $822.79 | 2019-2024 | Eleos Limb Salvage System |
| Next Science LLC | $384.88 | 2020-2024 | Surgx, Blastx, Xperience |
| Illuminoss Medical, INC. | $364.82 | 2023-2025 | Photodynamic Bone Stabilization Procedure Pack |
| Uoc USA INC | $363.27 | 2024-2025 | U-Star, Conformity, U2, U2 and Ustar II, Ustar II |
| Novartis Pharmaceuticals Corporation | $353.31 | 2023-2025 | |
| Emd Serono, INC. | $304.08 | 2025 | |
| Springworks Therapeutics, INC. | $195.97 | 2024-2025 | Ogsiveo |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocomposites INC | $174.42 | 2024-2025 | Stimulan |
| Acera Surgical, INC. | $161.00 | 2025 | Restrata Wound Matrix |
| Medacta USA, INC. | $154.95 | 2024 | |
| Orthofix Medical, INC. | $142.83 | 2023 | Truelok |
| Curvafix, INC. | $139.58 | 2025 | Curvafix Im Implant |
| Lima USA, INC. | $136.20 | 2021 | |
| Si-Bone, INC. | $135.63 | 2025 | |
| Zimmer Biomet Holdings, INC. | $134.62 | 2024 | |
| Flower Orthopedics Coporation | $124.81 | 2021 | |
| Horizon Therapeutics Plc | $120.92 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $120.41 | 2025 | |
| Linvatec Corporation | $96.85 | 2025 | Biobrace 23mm |
| Linkbio Corp | $94.17 | 2022 | |
| Depuy Synthes Sales INC. | $77.15 | 2021-2024 | Na |
| Sanara Medtech INC. | $53.88 | 2023 | Celleraterx |
| Pacira Pharmaceuticals Incorporated | $21.77 | 2024 | Exparel, Zilretta, Iovera |
| Smith+Nephew, INC. | $18.75 | 2019 | |
| Merck Sharp & Dohme LLC | $16.17 | 2019 | |
| Agios Pharmaceuticals, INC. | $13.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Cable listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.